.webp&w=3840&q=75)
Manufacture and Commercialisation of Stem Cell and Gene Therapies
The Manufacture and Commercialisation of Stem Cell and Gene Therapies program at University College London (UCL) is designed for individuals interested in the cutting-edge fields of stem cell and gene therapy. This one-year, full-time Master of Science (MSc) program focuses on the integration of scientific research and industry practices to develop therapies that can transform healthcare. The curriculum is tailored to equip students with essential skills in the biotechnology industry, focusing on practical applications and the latest advancements in biomedical science.
UCL is renowned for its world-class research and state-of-the-art facilities, ensuring students gain exposure to the latest technologies in stem cell and gene therapy. The program offers a strong foundation in the principles of biomedical science, while also focusing on the ethical and regulatory considerations required to bring new treatments to market. Graduates of this program will be well-prepared to take on roles in the rapidly growing field of regenerative medicine.
Key information
Key Facts
- Program Title: Master of Science in Manufacture and Commercialisation of Stem Cell and Gene Therapies
- Degree Type: Master of Science (MSc)
- Duration: 1 Year
- Mode of Study: Full-time, On Campus
- Application Deadline: 29th August 2026
- Location: University College London (UCL), United Kingdom
- Field of Study: Biomedical Science
- Language of Instruction: English
Program Structure
The program is structured into core modules that cover a range of topics essential for the manufacture and commercialization of stem cell and gene therapies. Students will study molecular biology, gene editing technologies, stem cell biology, and the principles of biotechnology. Additionally, the program includes practical laboratory sessions and a research project, which provide hands-on experience in the field. The curriculum is designed to ensure that graduates can bridge the gap between scientific innovation and real-world application in the biopharmaceutical industry.
Career Opportunities
Graduates of the MSc in Manufacture and Commercialisation of Stem Cell and Gene Therapies program will have access to a broad range of career opportunities in the biomedical and biopharmaceutical industries. These include roles in biotechnology companies, research institutions, and pharmaceutical firms. The skills gained during the program will prepare graduates to pursue careers in research, regulatory affairs, product development, and business management related to advanced therapies. There is also the opportunity to continue in academia or move into consultancy roles within the sector.
Why Choose This Program
This program at UCL stands out due to its combination of academic rigor and industry relevance. UCL is at the forefront of medical and scientific research, providing students with access to leading experts in the field. The program’s strong industry ties and emphasis on commercialization ensure that students gain valuable insights into how to translate scientific discoveries into marketable therapies. Students also benefit from UCL’s extensive network and the career support provided, which helps them to secure meaningful positions within the biotechnology and pharmaceutical sectors.
Contact Information
For further information, please contact the admissions office at:
Phone: +44 (0)20 7679 2000
Email: contact@ucl.ac.uk
Address: University College London, Gower Street, London WC1E 6BT, United Kingdom
